Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance
Open accessThe DOI matches its Crossref record; 164 of the 165 references it cites were found in a registry or an index.
Abstract
Depression in dementia is common, disabling and causes significant distress to patients and carers. Despite widespread use of antidepressants for depression in dementia, there is no evidence of therapeutic efficacy, and their use is potentially harmful in this patient group. Depression in dementia has poor outcomes and effective treatments are urgently needed. Understanding why antidepressants are ineffective in depression in dementia could provide insight into their mechanism of action and aid identification of new therapeutic targets. In this review we discuss why depression in dementia may be a distinct entity, current theories of how antidepressants work and how these mechanisms of action may be affected by disease processes in dementia. We also consider why clinicians continue to prescribe antidepressants in dementia, and novel approaches to understand and identify effective treatments for patients living with depression and dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is likely that for many people, depression in dementia differs from depression in those without dementia as brain changes in dementia, which vary between different subtypes of dementia, may mean that antidepressants which are effective in depression without dementia do not work. (533)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [533]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267 · cited 6×
“Depression is associated with several types of negative affective biases (see Table 3) including changes in reward processing, negative perception of social cues, greater attention to aversive information and increased recall of negative relative to positive information (Harmer et al., 2017).”
InfluentialHirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 2×
“…for Depression (Radloff, 1977); Inventory of Depressive Symptoms (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996); Montgomery – Åsberg Depression Rating Scale (Montgomery & Åsberg, 1979); Quick Inventoryof Depressive Symptoms (Rush et al., 2003); Zung Self-Rating Depression Scale (Zung, 1965).”
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813 · cited 3×
“…for Depression (Radloff, 1977); Inventory of Depressive Symptoms (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996); Montgomery – Åsberg Depression Rating Scale (Montgomery & Åsberg, 1979); Quick Inventoryof Depressive Symptoms (Rush et al., 2003); Zung Self-Rating Depression Scale (Zung, 1965).”
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965 · cited 2×
“The seven depression rating scales are: Beck Depression Inventory (Beck, Steer, Ball, & Ranieri, 1996); Centre of Epidemiological Studies Depression Scale; Hamilton Rating Scale for Depression (Radloff, 1977); Inventory of Depressive Symptoms (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996);…”
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 2×
“…for Depression (Radloff, 1977); Inventory of Depressive Symptoms (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996); Montgomery – Åsberg Depression Rating Scale (Montgomery & Åsberg, 1979); Quick Inventoryof Depressive Symptoms (Rush et al., 2003); Zung Self-Rating Depression Scale (Zung, 1965).”
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177 · cited 2×
“…1996); Centre of Epidemiological Studies Depression Scale; Hamilton Rating Scale for Depression (Radloff, 1977); Inventory of Depressive Symptoms (Rush, Gullion, Basco, Jarrett, & Trivedi, 1996); Montgomery – Åsberg Depression Rating Scale (Montgomery & Åsberg, 1979); Quick Inventoryof…”
Cognitive impairment in depression: a systematic review and meta-analysis
Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014) · Psychological Medicine · doi:10.1017/s0033291713002535 · Cited by 2,161 · cited 1×
“Impairments in executive function and memory are present in depressed patients and those with remitted depression v. controls (Rock, Roiser, Riedel, & Blackwell, 2014).”
Self-citationUneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953 · cited 3×
“Up to 80% of dopaminergic projections to the striatum from the SN are lost by the time of diagnosis (Cheng et al., 2010; Kish et al., 1988).”
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230 · cited 1×
“The monoamine hypothesis of depression is over 50 years old (Coppen, 1967).”
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · cited 3×
“Duration of illness correlates with loss of neurons in the SN (Cheng et al., 2010).”
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002 · cited 3×
“Noradrenaline (Locus coeruleus (LC)) AD pathology occurs early in the LC, leading to severe loss of LC neurons (over 60%) (Grudzien et al., 2007; Zarow et al., 2003).”
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947 · cited 11×
“BDNF promotes neuronal maturation, plasticity and synaptic transmission by increasing production of brain cholesterol which facilitates cell membrane phospholipid fluidity of lipid rafts where many antide-pressants interact (Casarotto et al., 2021).”
InfluentialZhao, Q.-F., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., Xu, W., Li, J.-Q., Wang, J., Lai, T.-J., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.069 · Cited by 916 · cited 2×
“Apathy affects 49% (Zhao et al., 2016) and 72% (Chow et al.”
Ruhé, H. G., Mason, N. S., & Schene, A. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001949 · Cited by 861
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739 · cited 1×
“However, the overlap of vascular dementia with AD pathology (Attems & Jellinger, 2014) and evidence that higher vascular risk factor scores predict reduced response to antidepressants in late life depression (Sheline et al., 2010) does not suggest this patient group will buck the trend of a…”
Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms
DeRubeis, R. J., Siegle, G. J., & Hollon, S. D. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2345 · Cited by 690 · cited 1×
“Other regions such as the amygdala, involved in processing emotional aspects of information and generating emotional reactions, project to the hippocampus which participates in the creation and maintenance of emotional associations in memory (DeRubeis, Siegle, & Hollon, 2008).”
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.034 · Cited by 663
Neuroscience of apathy and anhedonia: a transdiagnostic approach
Husain, M., & Roiser, J. P. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0029-9 · Cited by 640 · cited 2×
“Dopaminergic dysfunction is associated with motivational symptoms of depression including apathy and anhedonia which are poorly responsive to antidepressant treatment (Husain & Roiser, 2018; Le Heron et al., 2018).”
Self-citationHow do antidepressants work? New perspectives for refining future treatment approaches
Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30015-9 · Cited by 616 · cited 3×
“Depression is associated with several types of negative affective biases (see Table 3) including changes in reward processing, negative perception of social cues, greater attention to aversive information and increased recall of negative relative to positive information (Harmer et al., 2017).”
Attentional bias in anxiety and depression: The role of awareness
Mogg, K., Bradley, B. P., & Williams, R. (1995) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1995.tb01434.x · Cited by 559 · cited 1×
“(cid:129) However, negative attentional biases are dependent on duration of stimuli (Mogg, Bradley, & Williams, 1995), indicating that any bias could be driven by difficulty in disengaging from negative stimuli rather than overall attention.”
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535 · cited 5×
“Several studies report depressed patients categorise ambiguous facial expressions as more negative in the facial emotions recognition test (FERT) and have reduced sensitivity to happy faces (Roiser et al., 2012).”
InfluentialSelf-citationBanerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., Bentham, P., Fox, C., Holmes, C., Katona, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60830-1 · Cited by 532 · cited 2×
“Though relatively few trials of antidepressants for depression in dementia have been conducted to date and most have studied depression in Alzheimer’s dementia (AD), the largest and best quality studies have shown limited signal of any clinically meaningful difference (Banerjee et al., 2011).”
Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study
Singh-Manoux, A., Dugravot, A., Fournier, A., Abell, J., Ebmeier, K., Kivimäki, M., & Sabia, S. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0660 · Cited by 529 · cited 1×
“Substantial evidence supports the hypothesis that depression is an early prodromal symptom of dementia, commonly occurring up to 10 years prior to diagnosis, and a consequence of the distinct pathophysiology of individual dementia syndromes (Singh-Manoux et al., 2017).”
Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia.
Graham, N. L., Emery, T., & Hodges, J. R. (2004) · PubMed Central · Cited by 455
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants
Richardson-Jones, J. W., Craige, C. P., Guiard, B. P., Stephen, A., Metzger, K. L., Kung, H. F., Gardier, A. M., Dranovsky, A., David, D. J., Beck, S. G., et al. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.003 · Cited by 450 · cited 2×
“The time taken for 5-HT1A autoreceptors to desensitise has been theorised to be an explanation of the delayed clinical effects of antidepressant treatment, and differences in 5-HT1A receptor levels or have been associated with depression, and the response to antidepressants (Richardson-Jones et al., 2010).”
Uher, R., Perlis, R. H., Henigsberg, N., Zobel, A., Rietschel, M., Mors, O., Hauser, J., Dernovsek, M. Z., Souery, D., Bajs, M., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711001905 · Cited by 420 · cited 2×
“Motivational symptoms including apathy and anhedonia contribute to an ‘interest-activity’ cluster of depressive symptoms that predicts worse response to antidepressants in depression in the general population (Uher et al., 2012), but respond better than core mood symptoms to behavioural activation (Leontjevas et al.”
Ng, T. K. S., Ho, C. S. H., Tam, W. W. S., Kua, E. H., & Ho, R. C.-M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020257 · Cited by 413 · cited 1×
“Across different dementia disorders, BDNF is markedly reduced and has been implicated as a key pathological mechanism of neurodegeneration (Ng, Ho, Tam, Kua, & Ho, 2019; Zuccato & Cattaneo, 2009).”
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
Halliday, G. M., Li, Y. W., Blumbergs, P. C., Joh, T. H., Cotton, R. G. H., Howe, P. R. C., Blessing, W. W., & Geffen, L. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270405 · Cited by 408 · cited 8×
“Projections from the DRN are topographically organised rostrocaudally and innervate regions involved in mood regulation, motivation and memory, including the striatum, entorhinal cortex, hippocampus, pre-frontal cortex and amygdala (Steinbusch et al., 2021).”
InfluentialGrudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396 · cited 3×
“Noradrenaline (Locus coeruleus (LC)) AD pathology occurs early in the LC, leading to severe loss of LC neurons (over 60%) (Grudzien et al., 2007; Zarow et al., 2003).”
Distinguishing Alzheimer’s disease from other major forms of dementia
Karantzoulis, S., & Galvin, J. E. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.155 · Cited by 385 · cited 1×
“Profile of memory deficits differs in dementia subtypes and stage of disease: (cid:129) AD at its core is an amnestic syndrome with early impairment in episodic memory followed by deterioration in word finding, spatial cognition and executive function (Karantzoulis & Galvin, 2011).”
Frontotemporal Dementia: A Randomised, Controlled Trial with Trazodone
Lebert, F., Stekke, W., Hasenbroekx, C., & Pasquier, F. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077171 · Cited by 382 · cited 1×
“…RCTs of SSRIs (RCTs) found opposing results in terms of efficacy (Deakin, Rahman, Nestor, Hodges, & Sahakian, 2004; Moretti, Torre, Antonello, Cazzato, & Bava, 2003), though one trial of trazodone in 26 patients reported reduced depressive symptoms (Lebert, Stekke, Hasenbroekx, & Pasquier, 2004).”
The anatomy of apathy: a neurocognitive framework for amotivated behaviour
Le Heron, C., Apps., M. A. J., & Husain, M. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.07.003 · Cited by 380 · cited 3×
“Human and animal studies have shown that dopaminergic transmission is crucial in motivated behaviour and reward processing (Le Heron, Apps, & Husain, 2018).”
Apathy in Parkinson's disease: A systematic review and meta‐analysis
den Brok, M. G. H. E., van Dalen, J. W., van Gool, W. A., Moll van Charante, E. P., de Bie, R. M. A., & Richard, E. (2015) · Movement Disorders · doi:10.1002/mds.26208 · Cited by 376 · cited 1×
“This striking loss of dopaminergic neurons may explain why apathy and anhedonia are particularly common in PD, estimated to affect 40% (den Brok et al., 2015) and 46% (Lemke, Brecht, Koester, Kraus, & Reichmann, 2005) of patients, respectively.”
What has serotonin to do with depression?
Cowen, P. J., & Browning, M. (2015) · World Psychiatry · doi:10.1002/wps.20229 · Cited by 374 · cited 1×
“In the age of complex systems neurobiology and computational neuroscience, there is a consensus that such reductionist biochemical theories are over-simplifications (Cowen & Browning, 2015; Harmer, Duman, & Cowen, 2017).”
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Betts, M. J., Kirilina, E., Otaduy, M. C. G., Ivanov, D., Acosta-Cabronero, J., Callaghan, M. F., Lambert, C., Cardenas-Blanco, A., Pine, K., Passamonti, L., et al. (2019) · Brain · doi:10.1093/brain/awz193 · Cited by 365 · cited 1×
“Degeneration of the LC occurs early in AD and Parkinson ’ s disease (PD) (Betts et al., 2019).”
Self-citationCummings, J., Mintzer, J., Brodaty, H., Sano, M., Banerjee, S., Devanand, D. P., Gauthier, S., Howard, R., Lanctôt, K., Lyketsos, C. G., et al. (2015) · International Psychogeriatrics · doi:10.1017/s1041610214001963 · Cited by 355 · cited 1×
“Zhong, K. (2015). Agitation in cognitive disorders: International psycho-”
Self-citationO’Brien, J. T., Holmes, C., Jones, M., Jones, R., Livingston, G., McKeith, I., Mittler, P., Passmore, P., Ritchie, C., Robinson, L., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116680924 · Cited by 354 · cited 1×
“FTD guidelines support SSRI use to treat behavioural disinhibition and agitation despite no RCT having been conducted to date (O ’ Brien et al., 2017).”
Furukawa, T. A., Cipriani, A., Cowen, P. J., Leucht, S., Egger, M., & Salanti, G. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30217-2 · Cited by 322 · cited 1×
“…lack of therapeutic effect cannot be explained by age effects as depressed older adults without dementia respond as well to antidepressants as other age groups (Gerson, Belin, Kaufman, Mintz, & Jarvik, 1999; Gildengers et al., 2002), though the effective dose range differs (Furukawa et al., 2019).”
A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia
Huey, E. D., Putnam, K. T., & Grafman, J. (2006) · Neurology · doi:10.1212/01.wnl.0000191304.55196.4d · Cited by 299 · cited 2×
“One study found decreased striatal dopaminergic projections, and there are case reports of reduced pre-synaptic dopamine transporter binding in patients (Huey et al., 2006; Rinne et al., 2002).”
Sheline, Y. I., Pieper, C. F., Barch, D. M., Welsh-Boehmer, K., McKinstry, R. C., MacFall, J. R., D’Angelo, G., Garcia, K. S., Gersing, K., Wilkins, C., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.204 · Cited by 291 · cited 1×
“…(Attems & Jellinger, 2014) and evidence that higher vascular risk factor scores predict reduced response to antidepressants in late life depression (Sheline et al., 2010) does not suggest this patient group will buck the trend of a disappointing lack of efficacy of antidepressants in dementia.”
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
Kelly, S. C., He, B., Perez, S. E., Ginsberg, S. D., Mufson, E. J., & Counts, S. E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0411-2 · Cited by 286 · cited 3×
“There is considerable synergy between monoamine systems, for example co-release of dopamine and serotonin in the striatum, and innervation of the cholinergic system by the LC (Kelly et al., 2017; Zhou et al., 2005).”
InfluentialStoy, M., Schlagenhauf, F., Sterzer, P., Bermpohl, F., Hägele, C., Suchotzki, K., Schmack, K., Wrase, J., Ricken, R., Knutson, B., et al. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111416686 · Cited by 279 · cited 1×
“Activation in the ventral striatum is lower in both apathy and anhedonia (Husain & Roiser, 2018), and is directly altered by both serotonergic and dopaminergic medications (Admon et al., 2017; Stoy et al., 2012).”
Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics
Buch, A. M., & Liston, C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00789-3 · Cited by 274 · cited 3×
“However, this has led to studies highlighting how specific symptoms of depression respond differently to interventions and may predict overall response to treatment (Buch & Liston, 2021).”
Revisiting the theoretical and methodological foundations of depression measurement
Fried, E. I., Flake, J. K., & Robinaugh, D. J. (2022) · Nature Reviews Psychology · doi:10.1038/s44159-022-00050-2 · Cited by 274 · cited 1×
“List of depressive symptoms adapted from ref – (Fried, Flake, & Robinaugh, 2022). monoamine pathways (predominantly serotonin, noradrenaline and dopamine) plays a causal role in the development of depression.”
Taylor Tavares, J. V., Clark, L., Cannon, D. M., Erickson, K., Drevets, W. C., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.034 · Cited by 262 · cited 1×
“Depressed patients exhibit impairments in affective attention and attentional shifting (Roiser et al., 2012; Taylor Tavares et al., 2007): (cid:129) In emotional Stroop tasks patients exhibit delayed naming of the colour of negative words (Broomfield, Davies, MacMahon, Ali, & Cross, 2007; Roiser et…”
Emotion comprehension in the temporal variant of frontotemporal dementia
Rosen, H. J. (2002) · Brain · doi:10.1093/brain/awf225 · Cited by 252 · cited 1×
“Prominent hippocampal and amygdala atrophy is a signature pattern of AD and FTD respectively (Barnes et al., 2006) and is associated with loss of emotional and behavioural regulation (Rosen et al., 2002).”
Grinberg, L. T., Rüb, U., Ferretti, R. E. L., Nitrini, R., Farfel, J. M., Polichiso, L., Gierga, K., Jacob‐Filho, W., Heinsen, H., & Brazilian Brain Bank Study Group (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00997.x · Cited by 241
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
Lyness, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00057-x · Cited by 240 · cited 1×
“During the early stages of AD pathology (Braak stage I-II), the DRN is heavily affected by tau tangles (Rüb et al., 2000) and exhibits marked neurodegeneration, with estimates of up to 77% neuronal cells lost depending on disease stage (Lyness, Zarow, & Chui, 2003).”
Neurochemical Correlates of Major Depression in Primary Dementia
Zubenko, G. S., Moossy, J., & Kopp, U. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530020117023 · Cited by 233 · cited 1×
“Degeneration in the LC correlates with cognitive decline and has been associated with developing depression in AD (Grudzien et al., 2007; Zubenko, Moossy, & Kopp, 1990).”
Distinctive Cognitive Profiles in Alzheimer's Disease and Subcortical Vascular Dementia
Buckley, P. F. (2006) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70286-x · Cited by 224
Halahakoon, D. C., Kieslich, K., O’Driscoll, C., Nair, A., Lewis, G., & Roiser, J. P. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2139 · Cited by 222
Self-citationRahman, S., Nestor, P. J., Hodges, J. R., Sahakian, B. J., & Deakin, J. B. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1686-5 · Cited by 221
Antidepressants for treating depression in dementia
Bains, J., Birks, J., & Dening, T. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944 · Cited by 214 · cited 1×
“1) (Dudas, Malouf, McCleery, & Dening, 2018).”
Dementia of frontal lobe type: neuropathology and immunohistochemistry.
Mann, D. M., South, P. W., Snowden, J. S., & Neary, D. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.6.605 · Cited by 213 · cited 1×
“Though only mild atrophy has been reported in the SN and VTA in FTD, parkinsonism occurs in 30% of FTD patients (Mann, South, Snowden, & Neary, 1993; Park & Chung, 2013).”
(1976) · Progress in Brain Research · doi:10.1016/s0079-6123(08)60974-7 · Cited by 213
The Columbia University Scale for Psychopathology in Alzheimer's Disease
Devanand, D. P., Miller, L., Richards, M., Marder, K., Bell, K., Mayeux, R., & Stern, Y. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530280051022 · Cited by 211
Drui, G., Carnicella, S., Carcenac, C., Favier, M., Bertrand, A., Boulet, S., & Savasta, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.3 · Cited by 210 · cited 1×
“Greater atrophy and loss of pre-synaptic dopaminergic projections to the striatum is associated with increased apathy and anhedonia across neurodegenerative disorders (Drui et al., 2014; Le Heron et al., 2018).”
Behavioral Pathology in Alzheimer’s Disease (BEHAVE-AD) Rating Scale
Reisberg, B., Auer, S. R., & Monteiro, I. M. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297003529 · Cited by 209
Orgeta, V., Qazi, A., Spector, A., & Orrell, M. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148130 · Cited by 207
The role of noradrenaline in cognition and cognitive disorders
Holland, N., Robbins, T. W., & Rowe, J. B. (2021) · Brain · doi:10.1093/brain/awab111 · Cited by 204 · cited 3×
“The LC projects widely and is implicated in modulating attention, memory, cognitive flexibility and sleep (Holland et al., 2021; Swift et al., 2018).”
Erickson, K., Drevets, W. C., Clark, L., Cannon, D. M., Bain, E. E., Zarate, C. A., Charney, D. S., & Sahakian, B. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2171 · Cited by 203 · cited 2×
“(cid:129) In an affective go/no go task depressed patients respond slower to happy targets (Erickson et al., 2005).”
A FREQUENCY ADDENDUM TO THE BEHAVIORAL PATHOLOGY IN ALZHEIMER's DISEASE RATING SCALE (BEHAVE-AD)
Monteiro, I., Boksay, I., Auer, S. R., Torossian, C., Sinaiko, E., & Reisberg, B. (1999) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199911001-00147 · Cited by 201
Corelease of Dopamine and Serotonin from Striatal Dopamine Terminals
Zhou, F.-M., Liang, Y., Salas, R., Zhang, L., De Biasi, M., & Dani, J. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.010 · Cited by 187 · cited 3×
“There is considerable synergy between monoamine systems, for example co-release of dopamine and serotonin in the striatum, and innervation of the cholinergic system by the LC (Kelly et al., 2017; Zhou et al., 2005).”
Achterberg, W., Lautenbacher, S., Husebo, B., Erdal, A., & Herr, K. (2020) · PAIN Reports · doi:10.1097/pr9.0000000000000803 · Cited by 184
Impact of ambiguity and risk on decision making in mild Alzheimer's disease
Sinz, H., Zamarian, L., Benke, T., Wenning, G. K., & Delazer, M. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.02.002 · Cited by 178 · cited 1×
“(cid:129) AD: Only reinforcement learning in AD has been studied to date, with clear deficits (Delazer, Sinz, Zamarian, & Benke, 2007; Sinz, Zamarian, Benke, Wenning, & Delazer, 2008; Torralva, Dorrego, Sabe, Chemerinski, & Starkstein, 2000).”
Antidepressants for treating depression in dementia
Dudas, R., Malouf, R., McCleery, J., & Dening, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003944.pub2 · Cited by 175
Lai, M. K. P., Tsang, S. W. Y., Francis, P. T., Esiri, M. M., Keene, J., Hope, T., & Chen, C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02554-x · Cited by 173
Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms
Moretti, R., Torre, P., Antonello, R. M., Cazzato, G., & Bava, A. (2003) · European Neurology · doi:10.1159/000067021 · Cited by 172 · cited 1×
“…series designs, and the only RCTs of SSRIs (RCTs) found opposing results in terms of efficacy (Deakin, Rahman, Nestor, Hodges, & Sahakian, 2004; Moretti, Torre, Antonello, Cazzato, & Bava, 2003), though one trial of trazodone in 26 patients reported reduced depressive symptoms (Lebert, Stekke,…”
Dopaminergic-based pharmacotherapies for depression
Papakostas, G. I. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.12.002 · Cited by 168 · cited 1×
“Though not first-line and less commonly used, dopaminergic agents such as buproprion (a noradrenaline-dopamine reuptake inhibitor), and pramipexole (a dopamine partial agonist) are effective treatments in the management of depression (Papakostas, 2006).”
Lemke, M. R., Brecht, H. M., Koester, J., Kraus, P. H., & Reichmann, H. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.2.214 · Cited by 163 · cited 1×
“This striking loss of dopaminergic neurons may explain why apathy and anhedonia are particularly common in PD, estimated to affect 40% (den Brok et al., 2015) and 46% (Lemke, Brecht, Koester, Kraus, & Reichmann, 2005) of patients, respectively.”
Decision-making with explicit and stable rules in mild Alzheimer's disease
Delazer, M., Sinz, H., Zamarian, L., & Benke, T. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.01.006 · Cited by 158 · cited 1×
“(cid:129) AD: Only reinforcement learning in AD has been studied to date, with clear deficits (Delazer, Sinz, Zamarian, & Benke, 2007; Sinz, Zamarian, Benke, Wenning, & Delazer, 2008; Torralva, Dorrego, Sabe, Chemerinski, & Starkstein, 2000).”
Swift, K. M., Gross, B. A., Frazer, M. A., Bauer, D. S., Clark, K. J. D., Vazey, E. M., Aston-Jones, G., Li, Y., Pickering, A. E., Sara, S. J., et al. (2018) · Current Biology · doi:10.1016/j.cub.2018.09.054 · Cited by 158 · cited 1×
“The LC projects widely and is implicated in modulating attention, memory, cognitive flexibility and sleep (Holland et al., 2021; Swift et al., 2018).”
Barnes, J., Whitwell, J. L., Frost, C., Josephs, K. A., Rossor, M., & Fox, N. C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1434 · Cited by 152 · cited 1×
“Prominent hippocampal and amygdala atrophy is a signature pattern of AD and FTD respectively (Barnes et al., 2006) and is associated with loss of emotional and behavioural regulation (Rosen et al., 2002).”
Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia
Lanctot, K. L. (2001) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13.1.5 · Cited by 152 · cited 1×
“Degeneration in serotonergic pathways has also been implicated in the development of BPSD, including depression (Lanctôt, Herrmann, & Mazzotta, 2001; Vermeiren et al., 2015).”
Livingston, G., Barber, J., Marston, L., Rapaport, P., Livingston, D., Cousins, S., Robertson, S., La Frenais, F., & Cooper, C. (2017) · BJPsych Open · doi:10.1192/bjpo.bp.117.005181 · Cited by 148 · cited 1×
“Agitation is common in dementia affecting half of patients (Livingston et al., 2017), and is defined as inappropriate verbal, vocal, or motor activity that is not thought to be caused by an unmet need (Cummings et al., 2015).”
Chow, T. W., Binns, M. A., Cummings, J. L., Lam, I., Black, S. E., Miller, B. L., Freedman, M., Stuss, D. T., & van Reekum, R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.92 · Cited by 145 · cited 1×
“Apathy affects 49% (Zhao et al., 2016) and 72% (Chow et al., 2009) of Alzheimer ’ s disease (AD) and FTD patients respectively, markedly higher than that reported in older adults with depression without dementia (38”
Watt, J. A., Goodarzi, Z., Veroniki, A. A., Nincic, V., Khan, P. A., Ghassemi, M., Lai, Y., Treister, V., Thompson, Y., Schneider, R., et al. (2021) · BMJ · doi:10.1136/bmj.n532 · Cited by 143 · cited 1×
“Though there is evidence for the efficacy of some non-drug interventions in people with dementia (Orgeta, Qazi, Spector, & Orrell, 2015; Watt et al., 2021), therapeutic outcomes for patients with depression and dementia are poor (Fritze, Ehrt, Hortobagyi, Ballard, & Aarsland, 2011).”
Cognitive Decline in Patients With Dementia as a Function of Depression
Rapp, M. A., Schnaider-Beeri, M., Wysocki, M., Guerrero-Berroa, E., Grossman, H. T., Heinz, A., & Haroutunian, V. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181e898d0 · Cited by 142 · cited 1×
“Depression in dementia hastens cognitive decline, increases mortality, causes significant carer stress and accelerates admission to long-term care facilities (Asmer et al., 2018; Feng et al., 2010; Lavretsky et al., 2010; Rapp et al., 2011).”
Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels
Babulal, G. M., Ghoshal, N., Head, D., Vernon, E. K., Holtzman, D. M., Benzinger, T. L. S., Fagan, A. M., Morris, J. C., & Roe, C. M. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.04.004 · Cited by 142 · cited 1×
“In cognitively normal older adults, biomarkers of Alzheimer ’ s disease pathology are associated with subsequent depression and presence of depression accelerates cognitive decline (Babulal et al., 2016; Snowden et al., 2015).”
Francis, P. T., & Perry, E. K. (2007) · Movement Disorders · doi:10.1002/mds.21683 · Cited by 140 · cited 1×
“Depletion of LC neurons in AD is more closely correlated with disease severity and staging than cholinergic degeneration in the nucleus basalis of Meynert (Holland et al., 2021; (Francis & Perry, 2007; Halliday et al., 1990).”
Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study
Verdelho, A., Hénon, H., Lebert, F., Pasquier, F., & Leys, D. (2004) · Neurology · doi:10.1212/01.wnl.0000115107.66957.8c · Cited by 138 · cited 1×
“Few studies have investigated how depressive symptoms differ across dementia types or in comparison with the non-dementia depression (Ehrt, Brønnick, Leentjens, Larsen, & Aarsland, 2006; Riedel, Heuser, Klotsche, Dodel, & Wittchen, 2010; Verdelho, Hénon, Lebert, Pasquier, & Leys, 2004).”
Dopaminergic Enhancement of Striatal Response to Reward in Major Depression
Admon, R., Kaiser, R. H., Dillon, D. G., Beltzer, M., Goer, F., Olson, D. P., Vitaliano, G., & Pizzagalli, D. A. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16010111 · Cited by 136 · cited 1×
“Activation in the ventral striatum is lower in both apathy and anhedonia (Husain & Roiser, 2018), and is directly altered by both serotonergic and dopaminergic medications (Admon et al., 2017; Stoy et al., 2012).”
The evolution of Alzheimer's disease‐related cytoskeletal pathology in the human raphe nuclei
Rüb, U., Del Tredici, K., Schultz, C., Thal, D. R., Braak, E., & Braak, H. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2000.00291.x · Cited by 134 · cited 1×
“During the early stages of AD pathology (Braak stage I-II), the DRN is heavily affected by tau tangles (Rüb et al., 2000) and exhibits marked neurodegeneration, with estimates of up to 77% neuronal cells lost depending on disease stage (Lyness, Zarow, & Chui, 2003).”
Implicit memory bias in clinical and non-clinical depression
Bradley, B. P., Mogg, K., & Millar, N. (1996) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(96)00074-5 · Cited by 133 · cited 1×
“Preferential recall of negative emotional information in emotional word-based memory encoding tasks (Bradley, Mogg, & Millar, 1996).”
Troeung, L., Egan, S. J., & Gasson, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079510 · Cited by 132 · cited 1×
“It may also explain why depressive symptoms in PD are poorly responsive to serotonergic and noradrenergic antidepressants (Troeung, Egan, & Gasson, 2013) but can respond to dopaminergic agonists used to treat motor symptoms (van der Velden, Broen, Kuijf, & Leentjens, 2018).”
Ehrt, U., Brønnick, K., Leentjens, A. F. G., Larsen, J. P., & Aarsland, D. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1456 · Cited by 131 · cited 2×
“Few studies have assessed whether the phenomenology of depression in dementia is qualitatively different from depression in other populations (Ehrt et al., 2006; Riedel et al., 2010).”
Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults
Johnell, K., Jonasdottir Bergman, G., Fastbom, J., Danielsson, B., Borg, N., & Salmi, P. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4483 · Cited by 130 · cited 1×
“In fact, antidepressant use in dementia is not only ineffective but potentially harmful, as it is associated with increased risk of falls, hospitalisation and higher risk of mortality (Banerjee et al., 2021; Johnell et al., 2017).”
Social cognition in neurodegenerative disorders: a systematic review
Elamin, M., Pender, N. P., Hardiman, O. M., & Abrahams, S. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302817 · Cited by 126 · cited 14×
“Prominent hippocampal and amygdala atrophy is a signature pattern of AD and FTD respectively (Barnes et al., 2006) and is associated with loss of emotional and behavioural regulation (Rosen et al., 2002).”
InfluentialBergh, S., Selbaek, G., & Engedal, K. (2012) · BMJ · doi:10.1136/bmj.e1566 · Cited by 124
Maust, D. T., Kim, H. M., Chiang, C., & Kales, H. C. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0379 · Cited by 123 · cited 1×
“…for treatment of neuropathic pain, which is highly prevalent in depression and dementia (Achterberg, Lautenbacher, Husebo, Erdal, & Herr, 2019), and they are frequently (mis)used to treat agitation as a substitution strategy to avoid anti-psychotic prescription (Maust, Kim, Chiang, & Kales, 2018).”
van der Velden, R. M. J., Broen, M. P. G., Kuijf, M. L., & Leentjens, A. F. G. (2018) · Movement Disorders · doi:10.1002/mds.27465 · Cited by 123 · cited 1×
“It may also explain why depressive symptoms in PD are poorly responsive to serotonergic and noradrenergic antidepressants (Troeung, Egan, & Gasson, 2013) but can respond to dopaminergic agonists used to treat motor symptoms (van der Velden, Broen, Kuijf, & Leentjens, 2018).”
The substantia nigra and ventral tegmental area in Alzheimer’s disease and Down’s syndrome
Gibb, W. R., Mountjoy, C. Q., Mann, D. M., & Lees, A. J. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.2.193 · Cited by 122
Longitudinal Association of Dementia and Depression
Snowden, M. B., Atkins, D. C., Steinman, L. E., Bell, J. F., Bryant, L. L., Copeland, C., & Fitzpatrick, A. L. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.09.002 · Cited by 117 · cited 2×
“In cognitively normal older adults, biomarkers of Alzheimer ’ s disease pathology are associated with subsequent depression and presence of depression accelerates cognitive decline (Babulal et al., 2016; Snowden et al., 2015).”
Altieri, S. C., Garcia-Garcia, A. L., Leonardo, E. D., & Andrews, A. M. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn3002174 · Cited by 110
Wang, J., Li, Y., Huang, Z., Wan, W., Zhang, Y., Wang, C., Cheng, X., Ye, F., Liu, K., Fei, G., et al. (2018) · European Journal of Neurology · doi:10.1111/ene.13628 · Cited by 110 · cited 1×
“LC degeneration has been implicated in agitation and irritability in AD (Liu, Stringer, Reeves, & Howard, 2018) and depression in PD (Wang et al., 2018).”
Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia
Rinne, J. O., Laine, M., Kaasinen, V., Norvasuo-Heilä, M. K., Någren, K., & Helenius, H. (2002) · Neurology · doi:10.1212/wnl.58.10.1489 · Cited by 109 · cited 1×
“One study found decreased striatal dopaminergic projections, and there are case reports of reduced pre-synaptic dopamine transporter binding in patients (Huey et al., 2006; Rinne et al., 2002).”
Meta-Analysis of the Prevalence of Major Depressive Disorder Among Older Adults With Dementia
Asmer, M. S., Kirkham, J., Newton, H., Ismail, Z., Elbayoumi, H., Leung, R. H., & Seitz, D. P. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17r11772 · Cited by 109 · cited 2×
“Individuals with dementia are twice as likely as age-matched controls to develop major depressive disorder and up to one-third of all-cause dementia patients develop depression (Asmer et al., 2018).”
Calcium Dysregulation in Alzheimer's Disease: A Target for New Drug Development
Wang, Y., Shi, Y., & Wei, H. (2017) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000374 · Cited by 108
Molecular imaging of serotonin degeneration in mild cognitive impairment
Smith, G. S., Barrett, F. S., Joo, J. H., Nassery, N., Savonenko, A., Sodums, D. J., Marano, C. M., Munro, C. A., Brandt, J., Kraut, M. A., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.007 · Cited by 103 · cited 2×
“As a consequence of the degeneration in the DRN, lower cortical serotonin, serotonin metabolites (5-hydroxyindoleacetic acid) and reduced serotonin transporter levels (Smith et al., 2017) have been reported in AD and other dementia syndromes (van der Zande et al., 2019).”
Cognitive and affective theory of mind in dementia with Lewy bodies and Alzheimer’s disease
Heitz, C., Noblet, V., Phillipps, C., Cretin, B., Vogt, N., Philippi, N., Kemp, J., Petigny, X. D., Bilger, M., Demuynck, C., et al. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0179-9 · Cited by 100 · cited 1×
“(cid:129) Similar deficits in emotional perception have been reported in Lewy body dementia (LBD), PD and FTD (Elamin, Pender, Hardiman, & Abrahams, 2012; Heitz et al., 2016).”
Gerson, S. (1999) · Harvard Review of Psychiatry · doi:10.1093/hrp/7.1.1 · Cited by 99 · cited 1×
“…lack of therapeutic effect cannot be explained by age effects as depressed older adults without dementia respond as well to antidepressants as other age groups (Gerson, Belin, Kaufman, Mintz, & Jarvik, 1999; Gildengers et al., 2002), though the effective dose range differs (Furukawa et al., 2019).”
Ruthirakuhan, M., Herrmann, N., Vieira, D., Gallagher, D., & Lanctôt, K. L. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.02.003 · Cited by 98 · cited 1×
“The presence of apathy in late-onset depression in mild cognitive impairment (MCI) also predicts subsequent development of AD (Ruthirakuhan, Herrmann, Vieira, Gallagher, & Lanctôt, 2019).”
Apathy in Late-Life Depression: Common, Persistent, and Disabling
Yuen, G. S., Bhutani, S., Lucas, B. J., Gunning, F. M., AbdelMalak, B., Seirup, J. K., Klimstra, S. A., & Alexopoulos, G. S. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.06.005 · Cited by 97 · cited 2×
“, 2009) of Alzheimer’s disease (AD) and FTD patients respectively, markedly higher than that reported in older adults with depression without dementia (38%) (Yuen et al., 2015).”
Relationship between symptoms of depression and agitation in nursing home residents with dementia
Volicer, L., Frijters, D. H. M., & Van der Steen, J. T. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2800 · Cited by 96 · cited 1×
“Irritability is a key component of agitation in dementia and strongly associated with depressive symptoms, both of which worsen with dementia progression (Volicer, Frijters, & Van der Steen, 2012).”
Yang, Y. M., & Schmitt, H. P. (2001) · Acta Neuropathologica · doi:10.1007/s004010000293 · Cited by 90 · cited 14×
“Prominent hippocampal and amygdala atrophy is a signature pattern of AD and FTD respectively (Barnes et al., 2006) and is associated with loss of emotional and behavioural regulation (Rosen et al., 2002).”
InfluentialLifetime risk of depression: restricted to a minority or waiting for most?
Andrews, G., Poulton, R., & Skoog, I. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.6.495 · Cited by 90 · cited 1×
“Second, the lifetime risk of depression is high and it is estimated that up to half the population will experience one or more episodes of depression during their lifetime (Andrews, Poulton, & Skoog, 2005).”
Feng, L., Scherer, S. C., Tan, B. Y., Chan, G., Fong, N. P., & Ng, T. P. (2010) · International Psychogeriatrics · doi:10.1017/s1041610209991487 · Cited by 90 · cited 1×
“Depression in dementia hastens cognitive decline, increases mortality, causes significant carer stress and accelerates admission to long-term care facilities (Asmer et al., 2018; Feng et al., 2010; Lavretsky et al., 2010; Rapp et al., 2011).”
Ramanan, S., Bertoux, M., Flanagan, E., Irish, M., Piguet, O., Hodges, J. R., & Hornberger, M. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617716000837 · Cited by 90 · cited 1×
“However, overlapping memory deficits with AD in other domains occur (Ramanan et al., 2017).”
Martinez, C., Jones, R. W., & Rietbrock, S. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002080 · Cited by 89 · cited 1×
“In the UK over a quarter of all people living with dementia take an antidepressant and the rates of prescription are increasing (Martinez, Jones, & Rietbrock, 2013).”
Stability and transitions of depressive subtypes over a 2-year follow-up
Lamers, F., Rhebergen, D., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2012) · Psychological Medicine · doi:10.1017/s0033291712000141 · Cited by 88
Banerjee, S., High, J., Stirling, S., Shepstone, L., Swart, A. M., Telling, T., Henderson, C., Ballard, C., Bentham, P., Burns, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01210-1 · Cited by 88 · cited 1×
“In fact, antidepressant use in dementia is not only ineffective but potentially harmful, as it is associated with increased risk of falls, hospitalisation and higher risk of mortality (Banerjee et al., 2021; Johnell et al., 2017).”
Self-citationRiedel, O., Heuser, I., Klotsche, J., Dodel, R., Wittchen, H.-U., & GEPAD Study Group (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709351833 · Cited by 86 · cited 1×
“Few studies have assessed whether the phenomenology of depression in dementia is qualitatively different from depression in other populations (Ehrt et al., 2006; Riedel et al., 2010).”
Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies: A Randomized Controlled-trial
Culo, S., Mulsant, B. H., Rosen, J., Mazumdar, S., Blakesley, R. E., Houck, P. R., & Pollock, B. G. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181e6a4d7 · Cited by 83 · cited 1×
“To date only one randomised controlled trial (RCT) of a selective serotonin reuptake inhibitor (SSRI) in 14 patients has been conducted in Lewy body dementia (LBD) which did not show efficacy and found high overall burden of side-effects (Culo et al., 2010).”
Attention deficits in Alzheimer's disease and vascular dementia
McGuinness, B., Barrett, S. L., Craig, D., Lawson, J., & Passmore, A. P. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.164483 · Cited by 80 · cited 1×
“Attentional deficits are prominent across dementia subtypes (McGuinness, Barrett, Craig, Lawson, & Passmore, 2010).”
Allen, N. H. P., Gordon, S., Hope, T., & Burns, A. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.3.293 · Cited by 74 · cited 1×
“It proposes that diminished activity in & Burns, 1996).”
Sasaki, M., Shibata, E., Tohyama, K., Kudo, K., Endoh, J., Otsuka, K., & Sakai, A. (2008) · Neuroreport · doi:10.1097/wnr.0b013e328315a637 · Cited by 71 · cited 2×
“Dopaminergic neurons project from the ventral tegmental area (VTA) and substantia nigra (SN) to the striatum (Sasaki et al., 2008).”
Lavretsky, H., Zheng, L., Weiner, M. W., Mungas, D., Reed, B., Kramer, J. H., Jagust, W., Chui, H., & Mack, W. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020280 · Cited by 70 · cited 1×
“Depression in dementia hastens cognitive decline, increases mortality, causes significant carer stress and accelerates admission to long-term care facilities (Asmer et al., 2018; Feng et al., 2010; Lavretsky et al., 2010; Rapp et al., 2011).”
Reward processing in neurodegenerative disease
Perry, D. C., & Kramer, J. H. (2015) · Neurocase · doi:10.1080/13554794.2013.873063 · Cited by 69 · cited 16×
“Prominent hippocampal and amygdala atrophy is a signature pattern of AD and FTD respectively (Barnes et al., 2006) and is associated with loss of emotional and behavioural regulation (Rosen et al., 2002).”
InfluentialPerception of emotions in mild cognitive impairment and Alzheimer’s dementia: does intensity matter?
Elferink, M. W., van Tilborg, I. A. D. A., & Kessels, R. P. C. (2015) · Translational Neuroscience · doi:10.1515/tnsci-2015-0013 · Cited by 67
Hayes, J. F., Lundin, A., Wicks, S., Lewis, G., Wong, I. C. K., Osborn, D. P. J., & Dalman, C. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3907 · Cited by 67 · cited 1×
“Epidemiological evidence has found an association between L-type calcium channel antagonist use (e.g. verapamil hydrochloride) and reduced rates of psychiatric hospitalisation and self-harm in bipolar disorder (Hayes et al., 2019).”
Costello, H., Cooper, C., Marston, L., & Livingston, G. (2019) · Age and Ageing · doi:10.1093/ageing/afz118 · Cited by 67 · cited 1×
“High turnover of staff working shift patterns in long term-care facilities (Costello, Cooper, Marston, & Livingston, 2020) can also complicate the process of making an accurate diagnosis and subsequent monitoring of depressive symptoms.”
Self-citationPrevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis
Jester, D. J., Molinari, V., Zgibor, J. C., & Volicer, L. (2021) · International Psychogeriatrics · doi:10.1017/s1041610220004032 · Cited by 60 · cited 1×
“Despite the widespread use of antidepressants in patients with dementia (Breining et al., 2017; Jester, Molinari, Zgibor, & Volicer, 2021) there is little evidence of therapeutic efficacy (see Fig.”
Depressive Symptoms in Alzheimer’s Disease and Lewy Body Dementia: A One-Year Follow-Up Study
Fritze, F., Ehrt, U., Hortobagyi, T., Ballard, C., & Aarsland, D. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000332016 · Cited by 59 · cited 1×
“Though there is evidence for the efficacy of some non-drug interventions in people with dementia (Orgeta, Qazi, Spector, & Orrell, 2015; Watt et al., 2021), therapeutic outcomes for patients with depression and dementia are poor (Fritze, Ehrt, Hortobagyi, Ballard, & Aarsland, 2011).”
Course and rate of antidepressant response in the very old
Gildengers, A. G., Houck, P. R., Mulsant, B. H., Pollock, B. G., Mazumdar, S., Miller, M. D., Dew, M. A., Frank, E., Kupfer, D. J., & Reynolds, C. F. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00334-2 · Cited by 59 · cited 1×
“…lack of therapeutic effect cannot be explained by age effects as depressed older adults without dementia respond as well to antidepressants as other age groups (Gerson, Belin, Kaufman, Mintz, & Jarvik, 1999; Gildengers et al., 2002), though the effective dose range differs (Furukawa et al., 2019).”
The neurochemistry of agitation in Alzheimer’s disease: a systematic review
Liu, K. Y., Stringer, A., Reeves, S., & Howard, R. J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.03.003 · Cited by 59
Self-citationNord, C. L., Barrett, L. F., Lindquist, K. A., Ma, Y., Marwood, L., Satpute, A. B., & Dalgleish, T. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.16 · Cited by 57 · cited 1×
“More negative recall of information is a core negative affective bias found in depression, and antidepressant therapy has been consistently shown to be associated with activation of the amygdala (Nord et al., 2021).”
Normann, C., Frase, S., Haug, V., von Wolff, G., Clark, K., Münzer, P., Dorner, A., Scholliers, J., Horn, M., Vo Van, T., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.008 · Cited by 56 · cited 1×
“Animal studies have shown SSRIs to protect against stress-induced synaptic neuroplasticity via direct blockade of voltage-activated L-type Ca 2+ channels (Normann et al., 2018).”
Vermeiren, Y., Dam, D. V., Aerts, T., Engelborghs, S., Martin, J., & Deyn, P. P. D. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0090-1 · Cited by 54 · cited 1×
“Degeneration in serotonergic pathways has also been implicated in the development of BPSD, including depression (Lanctôt, Herrmann, & Mazzotta, 2001; Vermeiren et al., 2015).”
Costello, H., Berry, A. J., Reeves, S., Weil, R. S., Joyce, E. M., Howard, R. J., & Roiser, J. P. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327762 · Cited by 50 · cited 2×
“In PD, reward processing impairment is dependent on dopaminergic medication state and subcategory of reward processing (Costello et al., 2021).”
Self-citationFurther evidence of attention bias for negative information in late life depression
Broomfield, N. M., Davies, R., MacMahon, K., Ali, F., & Cross, S. M. B. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1655 · Cited by 49 · cited 1×
“…exhibit impairments in affective attention and attentional shifting (Roiser et al., 2012; Taylor Tavares et al., 2007): (cid:129) In emotional Stroop tasks patients exhibit delayed naming of the colour of negative words (Broomfield, Davies, MacMahon, Ali, & Cross, 2007; Roiser et al., 2012).”
New Perspective on Parkinsonism in Frontotemporal Lobar Degeneration
Park, H. K., & Chung, S. J. (2013) · Journal of Movement Disorders · doi:10.14802/jmd.13001 · Cited by 49 · cited 1×
“Though only mild atrophy has been reported in the SN and VTA in FTD, parkinsonism occurs in 30% of FTD patients (Mann, South, Snowden, & Neary, 1993; Park & Chung, 2013).”
Li, X., & Zhang, C. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.005 · Cited by 49 · cited 1×
“Antidepressants are effective for post-stroke depression in patients without dementia (Li & Zhang, 2020).”
Leontjevas, R., Teerenstra, S., Smalbrugge, M., Vernooij-Dassen, M. J. F. J., Bohlmeijer, E. T., Gerritsen, D. L., & Koopmans, R. T. C. M. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213001440 · Cited by 47 · cited 1×
“…apathy and anhedonia contribute to an ‘ interest-activity ’ cluster of depressive symptoms that predicts worse response to antidepressants in depression in the general population (Uher et al., 2012), but respond better than core mood symptoms to behavioural activation (Leontjevas et al., 2013).”
Depression in subjects with and without dementia: a comparison using GMS‐AGECAT
Janzing, J. G. E., Hooijer, C., van 't Hof, M. A., & Zitman, F. G. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.526 · Cited by 46 · cited 1×
“Studies of depressive symptom profile in dementia in long-term care facilities highlight how motivational symptoms such as apathy are common (Janzing, Hooijer, van ‘ t Hof, & Zitman, 2002), and clinician-rated irritability is the most prevalent depressive symptom (Borza et al., 2015).”
Impairments of Social Cognition and Decision Making in Alzheimer's Disease
Torralva, T., Dorrego, F., Sabe, L., Chemerinski, E., & Starkstein, S. E. (2000) · International Psychogeriatrics · doi:10.1017/s1041610200006463 · Cited by 45 · cited 1×
“(cid:129) AD: Only reinforcement learning in AD has been studied to date, with clear deficits (Delazer, Sinz, Zamarian, & Benke, 2007; Sinz, Zamarian, Benke, Wenning, & Delazer, 2008; Torralva, Dorrego, Sabe, Chemerinski, & Starkstein, 2000).”
Banning, L. C. P., Ramakers, I. H. G. B., Rosenberg, P. B., Lyketsos, C. G., Leoutsakos, J. S., & Initiative, A. D. N. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5418 · Cited by 45 · cited 1×
“Recent work using existing large cohorts has identified different trajectories of depressive symptoms in older adults depending on AD biomarker status (Banning, Ramakers, Rosenberg, Lyketsos, & Leoutsakos, 2021).”
Borza, T., Engedal, K., Bergh, S., Barca, M. L., Benth, J. Š., & Selbæk, G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.053 · Cited by 43 · cited 1×
“Studies of depressive symptom profile in dementia in long-term care facilities highlight how motivational symptoms such as apathy are common (Janzing, Hooijer, van ‘ t Hof, & Zitman, 2002), and clinician-rated irritability is the most prevalent depressive symptom (Borza et al., 2015).”
Frontotemporal Dementia and Pharmacologic Interventions
Kaye, E. D., Petrovic‐Poljak, A., Verhoeff, N. P. L. G., & Freedman, M. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.1.19 · Cited by 42
Fritze, S., Spanagel, R., & Noori, H. R. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14114 · Cited by 42 · cited 1×
“For example, the serotonin-1A (5-HT 1A ) autoreceptor controls serotonergic tone through feedback inhibition and has been hypothesised to lead to a reduction in synaptic serotonin levels early on in SSRI treatment (Fritze, Spanagel, & Noori, 2017).”
Trieu, C., Gossink, F. T., Stek, M. L., Scheltens, P., Pijnenburg, Y. A. L., & Dols, A. (2020) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000217 · Cited by 40 · cited 1×
“…dementia (FTD) where clinical use of SSRIs is widely advocated and seen as an effective therapy for depression and disinhibition in this patient group (Trieu et al., 2020), the evidence supporting its use is mixed (Huey, Putnam, & Grafman, 2006; Kaye, Petrovic-Poljak, Verhoeff, & Freedman, 2010).”
Steinbusch, H. W. M., Dolatkhah, M. A., & Hopkins, D. A. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.02.003 · Cited by 40 · cited 2×
“Projections from the DRN are topographically organised rostrocaudally and innervate regions involved in mood regulation, motivation and memory, including the striatum, entorhinal cortex, hippocampus, pre-frontal cortex and amygdala (Steinbusch et al., 2021).”
Elliott, M. S. J., Ballard, C. G., Kalaria, R. N., Perry, R., Hortobagyi, T., & Francis, P. T. (2009) · Brain · doi:10.1093/brain/awp069 · Cited by 39 · cited 2×
“For example, increased 5-HT 1A binding in the temporal cortex has been reported in vascular dementia (Elliott et al., 2009) but reduced binding in the same region has been found in AD which also correlated with higher agitation levels (Lai et al., 2003).”
Nunes, P. V., Nascimento, C. F., Kim, H. K., Andreazza, A. C., Brentani, H. P., Suemoto, C. K., Leite, R. E. P., Ferretti-Rebustini, R. E. D. L., Pasqualucci, C. A., Nitrini, R., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.025 · Cited by 37 · cited 1×
“Post-mortem studies have not supported a similar BDNF reduction in late-life depression compared to dementia (Nunes et al., 2018), and no study has yet investigated whether basal BDNF level predicts response to antidepressants.”
Diagnosis, Clinical Features, and Therapeutic Implications of Agitated Depression
Sampogna, G., Vecchio, V. D., Giallonardo, V., Luciano, M., & Fiorillo, A. (2019) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2019.10.011 · Cited by 37
Wong, S., Irish, M., Savage, G. R., Hodges, J. R., Piguet, O., & Hornberger, M. (2018) · Journal of Neuropsychology · doi:10.1111/jnp.12152 · Cited by 35 · cited 15×
“Prominent hippocampal and amygdala atrophy is a signature pattern of AD and FTD respectively (Barnes et al., 2006) and is associated with loss of emotional and behavioural regulation (Rosen et al., 2002).”
InfluentialDopamine and serotonin interplay for valence-based spatial learning
Wert-Carvajal, C., Reneaux, M., Tchumatchenko, T., & Clopath, C. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110645 · Cited by 35
Breining, A., Bonnet‐Zamponi, D., Zerah, L., Micheneau, C., Riolacci‐Dhoyen, N., Chan‐Chee, C., Deligne, J., Harlin, J.-M., Boddaert, J., Verny, M., et al. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4517 · Cited by 34
Strenziok, M., Pulaski, S. J., Krüeger, F., Zamboni, G., Clawson, D. M., & Grafman, J. H. (2011) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3182255a7c · Cited by 33 · cited 14×
“Prominent hippocampal and amygdala atrophy is a signature pattern of AD and FTD respectively (Barnes et al., 2006) and is associated with loss of emotional and behavioural regulation (Rosen et al., 2002).”
InfluentialAssociation between environmental stimulation and apathy in nursing home residents with dementia
Jao, Y., Liu, W., Williams, K. N., Chaudhury, H., & Parajuli, J. (2019) · International Psychogeriatrics · doi:10.1017/s1041610219000589 · Cited by 31 · cited 1×
“However, both apathy and irrit-ability are common in dementia in the absence of depression, and highly influenced by environmental factors (Jao, Liu, Williams, Chaudhury, & Parajuli, 2019).”
Hyde, A. J., May, B. H., Xue, C. C., & Zhang, A. L. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.02.022 · Cited by 29 · cited 1×
“Even if only acting as placebo, we know placebo is effective at improving symptoms in both depression and in dementia (Hyde, May, Xue, & Zhang, 2017).”
Komulainen, K., Airaksinen, J., Savelieva, K., Gluschkoff, K., Velázquez, R. G., Elovainio, M. J., & Jokela, M. M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00884-3 · Cited by 28 · cited 1×
“For example, network analysis of individual depressive symptoms in anti-depressant RCTs has identified improvement in low mood and insomnia as having greatest impact on subsequent remission and recovery (Komulainen et al., 2021).”
van der Zande, J. J., Joling, M., Happach, I. G., Vriend, C., Scheltens, P., Booij, J., & Lemstra, A. W. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102062 · Cited by 27 · cited 1×
“As a consequence of the degeneration in the DRN, lower cortical serotonin, serotonin metabolites (5-hydroxyindoleacetic acid) and reduced serotonin transporter levels (Smith et al., 2017) have been reported in AD and other dementia syndromes (van der Zande et al., 2019).”
Ohm, D. T., Peterson, C. S., Lobrovich, R., Cousins, K. A. Q., Gibbons, G. S., McMillan, C. T., Wolk, D. A., Deerlin, V. M. V., Elman, L. B., Spindler, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02210-1 · Cited by 26 · cited 1×
“However, a larger post-mortem study found marked tau burden and neurodegeneration in the LC, which was greater in FTD-tau than FTD-transactive response DNA binding protein (TDP) (Ohm et al., 2020).”
Negative Bias in the Perception and Memory of Emotional Information in Alzheimer Disease
Gallego, M. G., & Gómez-García, J. (2017) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716686833 · Cited by 22 · cited 1×
“(cid:129) Few studies have investigated affective memory bias in dementia and there is conflicting evidence on whether memory in dementia is sensitive to affective content (Fairfield, Colangelo, Mammarella, Di Domenico, & Cornoldi, 2017; Maria & Juan, 2017).”
Inhibitory control and affective valence processing in dementia of the alzheimer type
Doninger, N. A., & Bylsma, F. (2007) · Journal of Neuropsychology · doi:10.1348/174866407x180828 · Cited by 18 · cited 2×
“However, research into emotional attention bias in dementia is limited: (cid:129) Among patients with AD there is no difference between positive and negative words on the emotional Stroop task (Doninger & Bylsma, 2007).”
Pasquereau, B., Drui, G., Saga, Y., Richard, A., Millot, M., Météreau, É., Sgambato, V., Tobler, P. N., & Tremblay, L. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00991-x · Cited by 18 · cited 1×
“SSRIs such as fluoxetine bind at therapeutic doses in the ventral striatum and modify emotional valence and reward processing via changes in tonic and phasic activities of striatal Psychological Medicine neurons (Pasquereau et al., 2021).”
Affective false memories in Dementia of Alzheimer's Type
Fairfield, B., Colangelo, M., Mammarella, N., Domenico, A. D., & Cornoldi, C. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.036 · Cited by 12
Stan, G. F., Church, T. W., Randall, E., Harvey, J. R. M., Brown, J. T., Wilkinson, K. A., Hanley, J. G., & Marrion, N. V. (2022) · Scientific Reports · doi:10.1038/s41598-022-18648-0 · Cited by 9 · cited 1×
“Marked dysregulation of calcium homoeostasis is believed to play an important role in the development of AD neuropathology and hyperpho-sphorylated tau has been shown to directly impair L-type calcium channels (Stan et al., 2022; Wang, Shi, & Wei, 2017).”
Wang, H., & Jia, J. (2007) · PubMed · Cited by 1
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Self-citationCouteur, D. G. L., Hilmer, S. N., Glasgow, N., Naganathan, V., & Cumming, R. G. (2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg006.pub2 · Cited by 59
Treatment of Alzheimer Disease
Geldmacher, D. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001503 · Cited by 53
Depressive symptoms and cognitive decline in older adults
Forbes, M., Lotfaliany, M., Mohebbi, M., Reynolds, C. F., Woods, R. L., Orchard, S. G., Chong, T. T. ‐., Agustini, B., O'Neil, A. E., Ryan, J. L., et al. (2024) · International Psychogeriatrics · doi:10.1017/s1041610224000541 · Cited by 48
Depression in dementia with Lewy bodies: a critical update
Jellinger, K. A. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02669-8 · Cited by 39
Metadata
- Authors
- Costello, H., Roiser, J. P., & Howard, R.
- Affiliations
- University College London (GB)
- Corresponding author
- Costello, Harry
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2023-01-09
- Volume
- 53
- Issue
- 3
- Pages
- 654-667
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- PMC
- PMC9976038
- OpenAlex
- W4313877462
- Cited by
- 60
- References
- 165
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 17 · 2023: 7
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychological Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (101798/Z/13/Z, 175479)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression in dementia, antidepressants, treatment resistance, antidepressant mechanism, antidepressant efficacy, antidepressant prescribing, dementia, novel therapeutic targets
- MeSH terms
- Antidepressive Agents, Dementia, Humans, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.